Comparison in prolactin concentration during haloperidol and risperidone treatments in the same female patients with schizophrenia

被引：0
|
作者：
Yasui, N [1 ]
Kondo, T [1 ]
Suzuki, A [1 ]
Mihara, K [1 ]
Ono, S [1 ]
Kaneko, S [1 ]
机构：
[1] Hirosaki Univ, Sch Med, Dept Clin Pharmacol, Hirosaki, Aomori 036, Japan
来源：
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S67 / S68
页数：2
相关论文
共 50 条
  • [41] Comparison of the risk of adverse events between risperidone and haloperidol in delirium patients
    Miyaji, Shingo
    Yamamoto, Kenji
    Hoshino, Syunya
    Yamamoto, Hiroaki
    Sakai, Yoshiro
    Miyaoka, Hitoshi
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2007, 61 (03) : 275 - 282
  • [42] Relation between serum prolactin levels and antipsychotic response to risperidone in patients with schizophrenia
    Charan, Alladi
    Shewade, Deepak Gopal
    Rajkumar, Ravi Philip
    Chandrasekaran, Adithan
    PSYCHIATRY RESEARCH, 2016, 240 : 209 - 213
  • [43] Risperidone elevates prolactin levels to a greater extent among patients with paranoid schizophrenia
    Reactions Weekly, 2007, 1168 (1) : 3 - 3
  • [44] Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone
    Basson, BR
    Kinon, BJ
    Taylor, CC
    Szymanski, KA
    Gilmore, JA
    Tollefson, GD
    JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (04) : 231 - 238
  • [45] Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol
    Volavka, J
    Czobor, P
    Nolan, K
    Sheitman, B
    Lindenmayer, JP
    Citrome, L
    McEvoy, JP
    Cooper, TB
    Lieberman, JA
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2004, 24 (02) : 225 - 228
  • [46] Effects of olanzapine, risperidone, quetiapine or haloperidol on quality of life and functional status in patients with schizophrenia
    Huang, Y
    Kim, YH
    Jung, IK
    Habil, H
    Dossenbach, M
    Hodge, A
    McBride, M
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S407 - S408
  • [47] Extra-pyramidal signs and symptoms (EPS) in recent onset schizophrenia: A comparison of risperidone and haloperidol
    Kopala, L
    Rabinowitz, J
    Emsley, R
    McGorry, P
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 187 - 187
  • [48] Differences in the effect of risperidone and haloperidol on rCBF in patients with schizophrenia performing a practiced memory task
    Miller, DD
    O'Leary, DS
    Andreasen, NC
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 181 - 182
  • [49] Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder
    Bilder, RM
    Goldman, RS
    Volavka, J
    Czobor, P
    Hoptman, M
    Sheitman, B
    Lindenmayer, JP
    Citrome, L
    McEvoy, J
    Kunz, M
    Chakos, M
    Cooper, TB
    Horowitz, TL
    Lieberman, JA
    AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (06): : 1018 - 1028
  • [50] Efficacy and tolerability of quetiapine in patients with schizophrenia who switched from haloperidol, olanzapine or risperidone
    Larmo, I
    de Nayer, A
    Windhager, E
    Irmansyah
    Lindenbauer, B
    Rittmannsberger, H
    Platz, T
    Jones, AM
    Altman, C
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2005, 20 (08) : 573 - 581
12345